ATE303149T1 - Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil - Google Patents
Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetilInfo
- Publication number
- ATE303149T1 ATE303149T1 AT02703777T AT02703777T ATE303149T1 AT E303149 T1 ATE303149 T1 AT E303149T1 AT 02703777 T AT02703777 T AT 02703777T AT 02703777 T AT02703777 T AT 02703777T AT E303149 T1 ATE303149 T1 AT E303149T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- oral pharmaceutical
- proxetil
- cefpodoxim
- cefpodoxim proxetil
- Prior art date
Links
- LTINZAODLRIQIX-ZFEISNGRSA-N 1-propan-2-yloxycarbonyloxyethyl (6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical group N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N\OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-ZFEISNGRSA-N 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
- LTINZAODLRIQIX-FBXRGJNPSA-N cefpodoxime proxetil Chemical group N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N/OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-FBXRGJNPSA-N 0.000 abstract 1
- 229960004797 cefpodoxime proxetil Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN190DE2001 | 2001-02-27 | ||
| PCT/IB2002/000602 WO2002067943A1 (en) | 2001-02-27 | 2002-02-27 | Oral pharmaceutical composition of cefpodoxime proxetil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE303149T1 true ATE303149T1 (de) | 2005-09-15 |
Family
ID=11097036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02703777T ATE303149T1 (de) | 2001-02-27 | 2002-02-27 | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1365764B1 (de) |
| JP (1) | JP2004522782A (de) |
| KR (1) | KR20030087009A (de) |
| CN (1) | CN1505515A (de) |
| AT (1) | ATE303149T1 (de) |
| AU (1) | AU2002237462B2 (de) |
| BR (1) | BR0207640A (de) |
| DE (1) | DE60205870T2 (de) |
| EA (1) | EA006974B1 (de) |
| ES (1) | ES2248521T3 (de) |
| MX (1) | MXPA03007678A (de) |
| NZ (1) | NZ527867A (de) |
| OA (1) | OA12687A (de) |
| WO (1) | WO2002067943A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6766376B2 (en) | 2000-09-12 | 2004-07-20 | Sn Acquisition, L.L.C | Streaming media buffering system |
| WO2004016251A1 (en) * | 2002-08-16 | 2004-02-26 | Orchid Chemicals And Pharmaceuticals Ltd. | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| AU2002321743A1 (en) * | 2002-08-19 | 2004-03-03 | Orchid Health Care | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| WO2004105728A2 (en) * | 2003-05-27 | 2004-12-09 | Ranbaxy Laboratories Limited | Solid dispersions of cefpodoxime proxetil and processes for their preparation |
| JP2008540403A (ja) * | 2005-05-05 | 2008-11-20 | ルピン・リミテッド | セファロスポリンの安定化経口用医薬組成物 |
| MX2007014363A (es) * | 2005-05-16 | 2009-04-15 | Elan Pharma Int Ltd | Composiciones de liberacion controlada y en forma de nanoparticulas que comprenden una cefalosporina. |
| US8900637B2 (en) * | 2005-12-02 | 2014-12-02 | Lupin Limited | Stable taste masked formulations of cephalosporins |
| WO2008057058A1 (en) * | 2006-11-10 | 2008-05-15 | Nobel Ilac Sanayii Ve Ticaret As | Oral pharmaceutical compositions |
| CN101278914B (zh) * | 2008-01-02 | 2010-06-02 | 海南三叶美好制药有限公司 | 头孢泊肟酯干混悬剂组合物及其制备方法 |
| TR201001417A1 (tr) * | 2010-02-25 | 2011-09-21 | Sanovel İlaç San. Ve Ti̇c. A. Ş. | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu |
| TR201002878A2 (tr) | 2010-04-13 | 2011-10-21 | Bi̇lgi̇ç Mahmut | Sefpodoksim proksetil içeren farmasötik bileşimler. |
| WO2011152805A2 (en) * | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Pharmaceutical composition comprising cefpodoxime proxetil and clavulanic acid |
| TR201007106A1 (tr) * | 2010-08-25 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Sefpodoksim proksetil formülasyonları. |
| TR201007107A1 (tr) * | 2010-08-25 | 2012-03-21 | B�Lg�� Mahmut | Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları. |
| TR201009168A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Suda dağılan sefpodoksim proksetil formülasyonları. |
| JP5995284B2 (ja) * | 2010-12-03 | 2016-09-21 | 日本曹達株式会社 | 固形製剤 |
| WO2013145750A1 (ja) * | 2012-03-29 | 2013-10-03 | 杏林製薬株式会社 | カプセル製剤 |
| IN2015DN00637A (de) | 2012-07-27 | 2015-06-26 | Redhill Biopharma Ltd | |
| CN103142506B (zh) * | 2013-04-03 | 2015-02-25 | 天津医药集团津康制药有限公司 | 一种头孢泊肟酯颗粒剂及其制备方法 |
| EP2990039A4 (de) | 2013-04-25 | 2017-02-22 | Kyorin Pharmaceutical Co., Ltd. | Feste pharmazeutische zusammensetzung |
| ES2768651T3 (es) | 2013-04-25 | 2020-06-23 | Kyorin Seiyaku Kk | Composición farmacéutica sólida |
| KR101509168B1 (ko) * | 2013-06-10 | 2015-04-06 | 한국화학연구원 | 세팔로스포린 항생제의 서방형 제제 및 이를 포함하는 서방형 약제학적 조성물 |
| CN103301075B (zh) * | 2013-06-28 | 2015-11-18 | 山东罗欣药业集团股份有限公司 | 一种头孢克肟组合物混悬颗粒剂及其制备方法 |
| JP6292788B2 (ja) * | 2013-07-30 | 2018-03-14 | ライオン株式会社 | 錠剤及び錠剤の製造方法 |
| JP2016204260A (ja) * | 2013-10-04 | 2016-12-08 | 日本曹達株式会社 | 錠剤の製造方法 |
| CA2965473A1 (en) | 2014-10-23 | 2016-04-28 | Kyorin-Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
| CN104771368B (zh) * | 2015-04-08 | 2017-12-22 | 石家庄四药有限公司 | 头孢泊肟酯速释制剂及其制备方法 |
| CN113456599A (zh) * | 2020-03-30 | 2021-10-01 | 洛阳惠中兽药有限公司 | 一种头孢泊肟酯片的制备方法及其制备的头孢泊肟酯片 |
| CN113952313A (zh) * | 2021-08-26 | 2022-01-21 | 宁夏医科大学 | 一种头孢呋辛酯胶囊及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486425A (en) * | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
| US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| AT500063A1 (de) * | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
| KR20080056308A (ko) * | 2000-06-21 | 2008-06-20 | 큐비스트 파마슈티컬즈 인코포레이티드 | 항미생물제의 경구 흡수를 개선하기 위한 조성물 및 방법 |
-
2002
- 2002-02-27 OA OA1200300220A patent/OA12687A/en unknown
- 2002-02-27 BR BR0207640-3A patent/BR0207640A/pt not_active Application Discontinuation
- 2002-02-27 AT AT02703777T patent/ATE303149T1/de not_active IP Right Cessation
- 2002-02-27 KR KR10-2003-7011273A patent/KR20030087009A/ko not_active Withdrawn
- 2002-02-27 CN CNA028089766A patent/CN1505515A/zh active Pending
- 2002-02-27 ES ES02703777T patent/ES2248521T3/es not_active Expired - Lifetime
- 2002-02-27 MX MXPA03007678A patent/MXPA03007678A/es unknown
- 2002-02-27 WO PCT/IB2002/000602 patent/WO2002067943A1/en not_active Ceased
- 2002-02-27 JP JP2002567310A patent/JP2004522782A/ja active Pending
- 2002-02-27 AU AU2002237462A patent/AU2002237462B2/en not_active Ceased
- 2002-02-27 NZ NZ52786702A patent/NZ527867A/xx unknown
- 2002-02-27 EA EA200300937A patent/EA006974B1/ru not_active IP Right Cessation
- 2002-02-27 EP EP02703777A patent/EP1365764B1/de not_active Expired - Lifetime
- 2002-02-27 DE DE60205870T patent/DE60205870T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2248521T3 (es) | 2006-03-16 |
| DE60205870T2 (de) | 2006-06-29 |
| KR20030087009A (ko) | 2003-11-12 |
| MXPA03007678A (es) | 2004-03-16 |
| EA006974B1 (ru) | 2006-06-30 |
| JP2004522782A (ja) | 2004-07-29 |
| AU2002237462B2 (en) | 2006-05-18 |
| CN1505515A (zh) | 2004-06-16 |
| EA200300937A1 (ru) | 2004-04-29 |
| EP1365764B1 (de) | 2005-08-31 |
| DE60205870D1 (de) | 2005-10-06 |
| EP1365764A1 (de) | 2003-12-03 |
| OA12687A (en) | 2006-06-21 |
| WO2002067943A1 (en) | 2002-09-06 |
| BR0207640A (pt) | 2004-07-27 |
| NZ527867A (en) | 2004-12-24 |
| EP1365764A4 (de) | 2004-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60205870D1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
| CO5590918A2 (es) | Formulaciones | |
| NO20042739L (no) | Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan | |
| DK1300398T3 (da) | Propan-1,3-dionderivat | |
| CY1108067T1 (el) | Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης | |
| NO20034660L (no) | Spiropyrazolforbindelser, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene for fremstilling av farmasoytiske preparater | |
| HN1999000066A (es) | Formulaciones farmaceuticas | |
| PL375874A1 (pl) | Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| CY1110258T1 (el) | Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης | |
| CY1105387T1 (el) | Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου | |
| ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
| SE9901077D0 (sv) | Novel use | |
| NO20034556L (no) | Imidazotriazinon-holdige sammensetninger for nasal administrering | |
| CY1105039T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ | |
| TNSN06012A1 (en) | Emulsifying systems containing azetidine derivatives | |
| NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
| CY1106712T1 (el) | Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| MY142077A (en) | Semi-solid systems containing azetidine derivatives | |
| EE05380B1 (et) | FenletanoolamiiniÁkristallivorm,ÁselleÁvalmistamineÁjaÁsedaÁsisaldavadÁfarmatseutilisedÁkompositsioonid | |
| DE50003634D1 (de) | SPRAY, ENTHALTEND UBICHINON Qn | |
| AR023056A1 (es) | Composiciones farmaceuticas basadas en alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh | |
| DE60102704D1 (de) | Trioxepan verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |